396
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Sensitivity and specificity of ultrasonography as a screening tool for gestational diabetes mellitus

, , , , , , & show all
Pages 1348-1353 | Received 03 Jun 2011, Accepted 14 Oct 2011, Published online: 25 Nov 2011

References

  • Kelly L, Evans L, Messenger D. Controversies around gestational diabetes. Practical information for family doctors. Can Fam Physician 2005;51:688–695.
  • Maternal-fetal medicine Committee, . Medico-Legal CommitteeDavies GA. Ant Clinical Practice Guideline. J Obstet Gynaecol Can 2000;22:456–462.
  • American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26(Suppl 1):103–105.
  • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2003;27(Suppl 2):1–140.
  • Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 2004;103:1229–1234.
  • Perkins JM, Dunn JP, Jagasia SM. Perspectives in Gestational Diabetes Mellitus: A Review of Screening, Diagnosis, and Treatment. Clinical Diabetes 2007;25:57–62.
  • Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ 2004;328:915.
  • Preece R, Jovanovic L. New and future diabetes therapies: Are they safe during pregnancy? J Matern Fetal Neonatal Med 2002;12:365–375.
  • Langer O. Fetal macrosomia: Etiologic factors. Clin Obstet Gynecol 2000;43:283–297.
  • Weber HS, Copel JA, Reece EA, Green J, Kleinman CS. Cardiac growth in fetuses of diabetic mothers with good metabolic control. J Pediatr 1991;118:103–107.
  • Gandhi JA, Zhang XY, Maidman JE. Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am J Obstet Gynecol 1995;173:1132–1136.
  • Breitweser JA, Meyer RA, Sperling MA, Tsang RC, Kaplan S. Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr 1980;96:535–539.
  • Hornberger LK. Maternal diabetes and the fetal heart. Heart 2006;92:1019–1021.
  • Sharland GK, Allan LD. Normal fetal cardiac measurements derived by cross-sectional echocardiography. Ultrasound Obstet Gynecol 1992;2:175–181.
  • Larciprete G, Valensise H, Vasapollo B, Novelli GP, Parretti E, Altomare F, Di Pierro G, et al. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol 2003;22:591–597.
  • Badalian SS, Fox HE, Baxi LV, Chao CR. Doppler ultrasound characteristics of fetal nasal flow in pregnancies complicated by diabetes mellitus. J Matern Fetal Med 1996;5:206–210.
  • Zamlynski J, Bodzek P, Olejek A, Manka G, Grettka K, Kobylec-Zamlynska B. [Correlation between amniotic fluid index (AFI) and glucose concentration in amniotic fluid, glycaemia, glycosylated haemoglobin concentration during normal pregnancy and pregnancy complicated by insulin-dependent diabetes mellitus]. Med Wieku Rozwoj 2005;9:407–416.
  • Vink JY, Poggi SH, Ghidini A, Spong CY. Amniotic fluid index and birth weight: Is there a relationship in diabetics with poor glycemic control? Am J Obstet Gynecol 2006;195:848–850.
  • Maulik D, Lysikiewicz A, Sicuranza G. Umbilical arterial Doppler sonography for fetal surveillance in pregnancies complicated by pregestational diabetes mellitus. J Matern Fetal Neonatal Med 2002;12:417–422.
  • Thompson MO, Vines SK, Aquilina J, Wathen NC, Harrington K. Are placental lakes of any clinical significance? Placenta 2002;23:685–690.
  • Bethune M, Bell R. Evaluation of the measurement of the fetal fat layer, interventricular septum and abdominal circumference percentile in the prediction of macrosomia in pregnancies affected by gestational diabetes. Ultrasound Obstet Gynecol 2003;22:586–590.
  • Guariglia L, Rosati P, Bartolozzi F. Cardiac circumference measurement: Possible screening tool in early pregnancy for anomalous cardiac development. Fetal Diagn Ther 2006;21:134–139.
  • Awadh AM, Prefumo F, Bland JM, Carvalho JS. Assessment of the intraobserver variability in the measurement of fetal cardiothoracic ratio using ellipse and diameter methods. Ultrasound Obstet Gynecol 2006;28:53–56.
  • Merz E, Weber G. Placenta. In: Merz E, Bahlmann F. Ultrasound in Obstetrics and Gynecology. 2005. Volume 1: Obstetrics: 388–404; 2nd edition, Thieme, Stuttgart, New York.
  • Larciprete G, Valensise H, Vasapollo B, et al. Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies. Ultrasound Obstet Gynecol 2003;22:591–597.
  • Elchalal U, Ezra Y, Levi Y, Bar-Oz B, Yanai N, Intrator O, Nadjari M. Sonographically thick placenta: A marker for increased perinatal risk–a prospective cross-sectional study. Placenta 2000;21:268–272.
  • Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol 1990;162:1168–1173.
  • Jeanty P, Romero R, Cantraine F, Cousaert E, Hobbins JC. Fetal cardiac dimensions: A potential tool for the diagnosis of congenital heart defects. J Ultrasound Med 1984;3:359–364.
  • Chanthasenanont A, Somprasit C, Pongrojpaw D. Nomograms of the fetal heart between 16 and 39 weeks of gestation. J Med Assoc Thai 2008;91:1774–1778.
  • Reece EA, Holford T, Tuck S, Bargar M, O’Connor T, Hobbins JC. Screening for gestational diabetes: One-hour carbohydrate tolerance test performed by a virtually tasteless polymer of glucose. Am J Obstet Gynecol 1987;156:132–134.
  • Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436–472.
  • HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. NEJM 2008;358:1991–2002.
  • Reece EA, Leguizamón G, Wiznitzer A. Gestational diabetes: The need for a common ground. Lancet 2009;373:1789–1797.
  • Hillier TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;148:766–775.
  • Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768–773.
  • Berger H, Mathew S. Counterpoint: Selective Screening for Gestational Mellitus. Diabetes care 2010;33:31–39.
  • Blayo A, Mandelbrot L. Screening and diagnosis of gestational diabetes. Diabetes Metab 2004;30:575–580.
  • Montagnana M, Lippi G, Targher G, Fava C, Guidi GC. Glucose challenge test does not predict gestational diabetes mellitus. Intern Med 2008;47:1171–1174.
  • Soares J, Dornhorstt A, Beard RW. The case for screening for gestational diabetes. BMJ 1997;315:737–739.
  • Maslovitz S, Shimonovitz S, Lessing JB, Hochner-Celnikier D. The validity of oral glucose tolerance test after 36 weeks’ gestation. Eur J Obstet Gynecol Reprod Biol 2006;129:19–24.
  • Persson M, Winkvist A, Mogren I. Surprisingly low compliance to local guidelines for risk factor based screening for gestational diabetes mellitus - A population-based study. BMC Pregnancy Childbirth 2009;9:53.
  • Murgia C, Berria R, Minerba L, Sulis S, Murenu M, Portoghese E, Garau N, et al. Risk assessment does not explain high prevalence of gestational diabetes mellitus in a large group of Sardinian women. Reprod Biol Endocrinol 2008;6:26.
  • Moses R, Griffiths R, Davis W. Gestational diabetes: Do all women need to be tested? Aust N Z J Obstet Gynaecol 1995;35:387–389.
  • Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, Chatzianagnostou K, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003;62:131–137.
  • Whitelaw A. Subcutaneous fat in newborn infants of diabetic mothers: An indication of quality of diabetic control. Lancet 1977;1:15–18.
  • Hanna FW, Peters JR. Screening for gestational diabetes; past, present and future. Diabet Med 2002;19:351–358.
  • Harlass FE, Brady K, Read JA. Reproducibility of the oral glucose tolerance test in pregnancy. Am J Obstet Gynecol 1991;164:564–568.
  • Brody SC, Harris R, Lohr K. Screening for gestational diabetes: A summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 2003;101:380–392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.